Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Arcus Biosciences (RCUS) Return on Capital Employed (2018 - 2025)

Arcus Biosciences (RCUS) has 6 years of Return on Capital Employed data on record, last reported at 0.35% in Q4 2023.

  • For Q4 2023, Return on Capital Employed fell 11.0% year-over-year to 0.35%; the TTM value through Dec 2023 reached 0.35%, down 11.0%, while the annual FY2023 figure was 0.34%, 11.0% down from the prior year.
  • Return on Capital Employed reached 0.35% in Q4 2023 per RCUS's latest filing, down from 0.3% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 0.06% in Q3 2022 and bottomed at 0.58% in Q1 2020.
  • Average Return on Capital Employed over 5 years is 0.24%, with a median of 0.25% recorded in 2021.
  • Peak YoY movement for Return on Capital Employed: skyrocketed 44bps in 2022, then tumbled -35bps in 2023.
  • A 5-year view of Return on Capital Employed shows it stood at 0.47% in 2019, then surged by 61bps to 0.19% in 2020, then skyrocketed by 128bps to 0.05% in 2021, then tumbled by -572bps to 0.24% in 2022, then tumbled by -46bps to 0.35% in 2023.
  • Per Business Quant database, its latest 3 readings for Return on Capital Employed were 0.35% in Q4 2023, 0.3% in Q2 2023, and 0.27% in Q1 2023.